首页> 外国专利> A CONTROLLED RELEASE FORMULATION FOR ENHANCED ORAL BIOAVAILABILITY OF HYDROPHOBIC DRUGS

A CONTROLLED RELEASE FORMULATION FOR ENHANCED ORAL BIOAVAILABILITY OF HYDROPHOBIC DRUGS

机译:增强药物的口服生物利用度的受控释放配方

摘要

The present invention relates to formulation of self-assembled core-shell polymeric system for enhanced oral bioavailability of hydrophobic traveler drug candidates and process for preparation thereof. The coreshell structured miceller formulation comprises hydrophobic traveler drug candidate as a core part surrounded by shell of a polymer cum surfadant pluronic Fl27. Characterization revealed that standardized miceller formulation of amphotericin B has particle size less than I 00 nm with 65% entrapment or drug payload. The oral bioavailability and phannacokinetic studies reported that miceller formulation provides hydrophobic traveler drug candidate amphotericin B in a controlled manner with enhanced oral bioavailability compared to pure drug suspension as well as marketed formulations.
机译:本发明涉及用于提高疏水性旅行药物候选物的口服生物利用度的自组装核-壳聚合物体系的制剂及其制备方法。核壳结构的胶束制剂包含疏水性旅行药物候选物作为被聚合物和表面活性剂多聚Pluron Fl27的壳包围的核心部分。表征表明,两性霉素B的标准化胶束制剂的粒径小于1 00 nm,有65%的包封或药物有效载荷。口服生物利用度和人体动力学研究报告说,与纯药物悬浮液和市售制剂相比,胶束制剂以受控方式为疏水性旅行者药物候选两性霉素B提供了增强的口服生物利用度。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号